APPLICATION SITE JOINT SWELLING

This adverse event was reported 5 times

These drugs are most commonly taken by patients reporting APPLICATION SITE JOINT SWELLING:

# Drug Count
0 ALLANTOIN 1
1 CRISABOROLE 1
2 HYDROXYUREA 1
3 MECHLORETHAMINE HYDROCHLORIDE 1
4 PACLITAXEL 1
5 RIVAROXABAN 1
6 TAPINAROF 1
See all common drugs associated with APPLICATION SITE JOINT SWELLING

APPLICATION SITE JOINT SWELLING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAPINAROF 1 0.0005
1 MECHLORETHAMINE HYDROCHLORIDE 1 0.0004
2 ALLANTOIN 1 0.0003
3 CRISABOROLE 1 0.0001
4 HYDROXYUREA 1 0.0000
5 PACLITAXEL 1 0.0000
6 RIVAROXABAN 1 0.0000
See all drugs enriched for association with APPLICATION SITE JOINT SWELLING

APPLICATION SITE JOINT SWELLING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aryl Hydrocarbon Receptor Agonist [EPC] 1 0.0005
1 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 1 0.0000
3 Alkylating Drug [EPC] 1 0.0000
4 Factor Xa Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with APPLICATION SITE JOINT SWELLING